Observational studyBritish journal of haematology2026
Endocrinopathies and growth in a UK cohort of children with transfusion dependent thalassaemia.
Observational study in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endocrine complications are recognised in transfusion-dependent thalassaemia (TDT), largely due to iron overload. This is the first study in the United Kingdom evaluating growth and endocrine outcomes in children with TDT at a UK tertiary centre. This observational cohort study included 50 individuals aged 2-25 years with TDT under a paediatric haemoglobinopathy service. Data up to 18 years of age were collected retrospectively and prospectively. Short stature was defined as height standard deviations score (SDS) <-2. Disproportionate truncal shortening was defined as leg length (LL) SDS minus sitting height (SH) SDS >1. Twelve (24%) patients had short stature (height SDS <-2) and only one was short for parental height. 23/29 (79.3%) had disproportionate truncal shortening with LL SDS-SH SDS >1. There was no difference in height SDS, SH SDS, LL SDS-SH SDS when comparing those with the highest average liver iron concentration (24.03 mg/g dry weight) to those with the lowest (5.04 mg/g dry weight). One had growth hormone deficiency with central hypothyroidism. Hypogonadism, thyroid dysfunction and impaired glucose tolerance were rare in our cohort. In this UK cohort, short stature was mostly familial, and endocrinopathies were uncommon, possibly reflecting optimised transfusion and chelation practices. In contrast, truncal shortening is common.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.